Figure 1From: Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report Fasting serum glucose levels during induction therapy with L-Asp and protocol III without L-Asp (Day 1–16). Monitoring of fasting serum glucose shows hypoglycemia during the estimated L-asp active period, displayed as the zone between dashed lines (——−−−−). PSL denotes predonisolone; VCR, vincristine; CPA, cyclophosphamide; DNR, daunorubicin; L-Asp, L-asparaginase; IT, intrathecal injection; DEX, dexamethasone; DOX, doxorubicin; and Das, dasatinib.Back to article page